Trade QTTB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Q32 Bio Inc. (QTTB) is trading at US$11.69, down 2.50% today as of Sep 8, 16:00 EDT. The company has a market capitalisation of US$475.42M. Over the past 52 weeks, QTTB has traded between US$1.69 and US$23.57. On Syfe you can trade QTTB with $0 commission and add it to your watchlist.
| Previous close | US$11.99 |
|---|---|
| Market cap | US$475.42M |
| 52-week range | US$1.69 – US$23.57 |
| Volume | 592.92K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Q32 Bio Inc.
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.
Year: 2024
Q32 Bio Registers 6.9 Million Shares for Resale
Jul 17, 8:39 PM · MT Newswires
Q32 Bio Prices $200 Million Offering of Stock, Pre-funded Warrants
Jul 15, 7:34 AM · MT Newswires
Q32 Bio Launches $200 Million Public Stock Offering
Jul 13, 8:18 PM · MT Newswires
--Mizuho Securities Raises Q32 Bio Price Target to $36 From $14, Outperform Rating Kept
Jul 13, 6:33 PM · MT Newswires
Q32 Bio Inc. (QTTB) stock is trading at US$11.69, -2.50% from the previous close of US$11.99.
The market cap for Q32 Bio Inc. (QTTB) stock is approximately US$475.42M.
The 52-week high for Q32 Bio Inc. (QTTB) stock is US$23.57.
The 52-week low for Q32 Bio Inc. (QTTB) stock is US$1.69.
Q32 Bio Inc. (QTTB) does not currently pay a dividend.
Stay on top of QTTB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
